You searched for "lesion"
Navigating challenges and embracing growth
Embarking on a career in ophthalmology is both exhilarating and challenging. Moving through the various stages of training, from foundation years to specialty training, brings a steep learning curve and intense demands, often necessitating significant adaptations in both professional and...Running a high-volume nurse led intravitreal service using the Sp.eye device – the Stanley Eye Unit experience
Introduction The vast majority of ophthalmology units utilise allied healthcare professionals (AHPs) to deliver intravitreal injections (IVIs). The Royal College of Ophthalmologists issued a statement 10 years ago advocating the use of non-medical practitioners performing IVIs [1]. The main benefit...Andean Medical Mission in action 2025
Dear friends and supporters, What 12 months it has been for the Andean Medical Mission! Thanks to your encouragement and generosity, we’ve been able to continue our work to eliminate avoidable blindness in the Beni region of Bolivia — and...ABDO welcomes Johnson & Johnson Vision as first Gold CPD Partner and exclusive 360˚ support programme launched
The Association of British Dispensing Opticians (ABDO) is pleased to announce Johnson & Johnson Vision as its first Gold CPD Partner (Contact Lens Opticians) – alongside the launch of an exclusively curated 360˚ support programme. Recognising the importance of the...Moorfields International refractive symposium
The Moorfields International refractive symposium covers contemporary vision correction surgery to surgeons in the UK and around the world. Taking place on Thursday 24 April at the Royal College of Physicians in London (08:30 - 17:45), the symposium aims to...
Children with Vision Impairment: Assessment, Development, and Management
Childhood blindness is a major public health concern worldwide with several implications ranging from a child’s development, education, and employment opportunities to social and functional challenges. This book offers a succinct, sequential approach to understanding conditions which lead to visual...
Four year outcomes of macular degeneration treated with ranibizumab
The authors report on a retrospective study of neovascular age-related macular degeneration (AMD) patients treated with a variable ranibizumab dosing regimen over a period of four years (from January 2007 to December 2011). A total of 600 treatment naïve eyes...
